Latest Insider Transactions at Treace Medical Concepts, Inc. (TMCI)
This section provides a real-time view of insider transactions for Treace Medical Concepts, Inc. (TMCI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TREACE MEDICAL CONCEPTS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TREACE MEDICAL CONCEPTS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$25,000
$1.05 P/Share
|
|
Feb 09
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
3,873
-100.0%
|
$77,460
$20.16 P/Share
|
|
Feb 09
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,873
+50.0%
|
$3,873
$1.05 P/Share
|
|
Feb 08
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
21,127
-100.0%
|
$422,540
$20.02 P/Share
|
|
Feb 08
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,127
+50.0%
|
$21,127
$1.05 P/Share
|
|
Feb 04
2022
|
James T Treace |
SELL
Bona fide gift
|
Indirect |
450,000
-44.72%
|
-
|
|
Jan 19
2022
|
James T Treace |
SELL
Open market or private sale
|
Direct |
32,063
-2.26%
|
$577,134
$18.99 P/Share
|
|
Jan 18
2022
|
James T Treace |
SELL
Open market or private sale
|
Direct |
42,937
-1.47%
|
$815,803
$19.68 P/Share
|
|
Jan 13
2022
|
Thomas E Timbie Director |
SELL
Bona fide gift
|
Indirect |
95,000
-15.83%
|
-
|
|
Jan 11
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
8,838
-100.0%
|
$176,760
$20.12 P/Share
|
|
Jan 11
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,838
+46.03%
|
$8,838
$1.31 P/Share
|
|
Jan 10
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
38,862
-100.0%
|
$777,240
$20.16 P/Share
|
|
Jan 10
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,862
+47.04%
|
$38,862
$1.57 P/Share
|
|
Jan 05
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
800
-100.0%
|
$16,000
$20.02 P/Share
|
|
Jan 05
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
800
+50.0%
|
$800
$1.57 P/Share
|
|
Jan 04
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
500
-100.0%
|
$10,000
$20.0 P/Share
|
|
Jan 04
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$500
$1.57 P/Share
|
|
Jan 03
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$20,000
$20.02 P/Share
|
|
Jan 03
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$1,000
$1.57 P/Share
|
|
Dec 29
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,075
-0.06%
|
$52,275
$17.01 P/Share
|
|
Dec 28
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
1,563
-99.87%
|
$25,008
$16.88 P/Share
|
|
Dec 28
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,760
-0.36%
|
$316,160
$16.99 P/Share
|
|
Dec 27
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
6,437
-80.44%
|
$109,429
$17.46 P/Share
|
|
Dec 27
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
17,165
-0.31%
|
$291,805
$17.44 P/Share
|
|
Dec 23
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
12,610
-61.18%
|
$201,760
$16.9 P/Share
|
|
Dec 23
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,795
-0.42%
|
$364,720
$16.96 P/Share
|
|
Dec 22
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
23,390
-53.16%
|
$374,240
$16.28 P/Share
|
|
Dec 22
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
41,710
-0.75%
|
$667,360
$16.29 P/Share
|
|
Dec 21
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
14,881
-12.99%
|
$238,096
$16.24 P/Share
|
|
Dec 21
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
37,584
-0.34%
|
$601,344
$16.23 P/Share
|
|
Dec 20
2021
|
James T Treace |
BUY
Other acquisition or disposition
|
Direct |
406,183
+21.75%
|
-
|
|
Dec 20
2021
|
James T Treace |
BUY
Other acquisition or disposition
|
Indirect |
406,183
+28.76%
|
-
|
|
Dec 20
2021
|
James T Treace |
SELL
Other acquisition or disposition
|
Indirect |
1,353,944
-49.08%
|
-
|
|
Dec 20
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
16,119
-0.56%
|
$241,785
$15.99 P/Share
|
|
Dec 20
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,911
-0.21%
|
$366,576
$16.03 P/Share
|
|
Dec 15
2021
|
James T Treace |
SELL
Open market or private sale
|
Direct |
75,000
-3.32%
|
$1,200,000
$16.46 P/Share
|
|
Nov 24
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
56,000
-0.5%
|
$952,000
$17.83 P/Share
|
|
Nov 24
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
17,000
-1.18%
|
$289,000
$17.83 P/Share
|
|
Nov 23
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
56,000
-0.49%
|
$952,000
$17.69 P/Share
|
|
Nov 23
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
17,000
-0.58%
|
$289,000
$17.89 P/Share
|
|
Nov 22
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
53,000
-0.46%
|
$954,000
$18.73 P/Share
|
|
Nov 22
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
16,000
-0.54%
|
$288,000
$18.95 P/Share
|
|
Nov 17
2021
|
James T Treace |
SELL
Open market or private sale
|
Direct |
25,000
-1.16%
|
$500,000
$20.33 P/Share
|
|
Nov 16
2021
|
James T Treace |
SELL
Open market or private sale
|
Direct |
25,000
-1.15%
|
$500,000
$20.86 P/Share
|
|
Nov 15
2021
|
James T Treace |
SELL
Open market or private sale
|
Direct |
25,000
-0.57%
|
$500,000
$20.91 P/Share
|
|
Nov 12
2021
|
James T Treace |
SELL
Bona fide gift
|
Direct |
600,000
-34.68%
|
-
|
|
Nov 10
2021
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
25,000
-99.12%
|
$525,000
$21.87 P/Share
|
|
Nov 10
2021
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$25,000
$1.57 P/Share
|
|
Oct 27
2021
|
James T Treace |
SELL
Bona fide gift
|
Direct |
400,000
-9.87%
|
-
|
|
Oct 22
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
58,089
-0.5%
|
$1,161,780
$20.95 P/Share
|